3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
4
Warts
1
Neoplasm Metastasis
1
Metabolic Syndrome
1
Heart Failure
1
Cardiovascular Diseases
1
Interventions
Echocardiography
4
sacubitril and valsartan sodium hydrate drug combination
3
Standard of Care
3
Nutrition Assessment
3
Exercise
3
Electrocardiography
3
Carvedilol
3
dapagliflozin
2
Surveys and Questionnaires
2
Spironolactone
2
Ivabradine
2
Blood Specimen Collection
2
Atorvastatin
2
ziprasidone
1
pertuzumab
1
pegfilgrastim
1
nicotinamide-beta-riboside
1
empagliflozin
1
candesartan
1
Zolpidem
1
Watchful Waiting
1
Warfarin
1
Vincristine
1
Vecuronium Bromide
1
Vascular Stiffness
1
Vancomycin
1
Valsartan
1
Trastuzumab
1
Tranexamic Acid
1
Tobramycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Heart Failure
×
Pyruvic Acid
×
Clear all
NCT06645691
2024-12-06
POLARIC-13
National Heart Centre Singapore
Phase 2
Recruiting
200 enrolled